D
Protagonist Therapeutics, Inc. PTGX
$58.36 $2.173.86% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -69.38% -65.34% 448.54% 221.61% 223.50%
Total Depreciation and Amortization -15.07% -12.64% -12.59% -3.89% 0.75%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 31.29% 24.22% 15.09% 13.75% 6.84%
Change in Net Operating Assets -253.90% 196.29% -528.41% 583.15% 527.95%
Cash from Operations -82.92% 632.15% 362.19% 293.80% 297.19%
Capital Expenditure -252.53% -97.15% -122.50% -61.21% -65.79%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -62.98% -844.46% -671.37% -1,418.29% -260.67%
Cash from Investing -63.82% -829.85% -662.86% -1,455.90% -262.08%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -33.07% -79.95% -84.55% -86.60% -66.18%
Repurchase of Common Stock 20.17% 62.25% 21.98% 21.98% 22.18%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -33.24% -80.10% -84.83% -86.89% -66.43%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -255.52% -173.34% -246.73% -227.92% 4.44%